LLY Eli Lilly and Co
- 724.870
- -7.330-1.00%
- 730.615
- +5.745+0.79%
Eli Lilly and Co News
Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-Director JOHNSON KIMBERLY H
Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-Director LUCIANO JUAN R
Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-Director Sulzberger Gabrielle
Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-Director Hedley Mary Lynne
Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-Director Alvarez Ralph
Eli Lilly and Co | PX14A6G: Notice of exempt solicitation
Eli Lilly and Co | PX14A6G: Notice of exempt solicitation
Eli Lilly and Co | PX14A6G: Notice of exempt solicitation
Eli Lilly and Co | PX14A6G: Notice of exempt solicitation
Eli Lilly and Co | PX14A6G: Notice of exempt solicitation
Eli Lilly and Co | DEFA14A: Others
Eli Lilly and Co | DEF 14A: Definitive information statements
Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-Director Sulzberger Gabrielle
Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-Director LUCIANO JUAN R
Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-Director JOHNSON KIMBERLY H
Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-Director Hedley Mary Lynne
Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-Director Alvarez Ralph
Eli Lilly and Co | 144: Notice of proposed sale of securities pursuant to Rule 144
Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-Officer Zakrowski Donald A
Eli Lilly and Co | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Analysis
Price Target
No Data
